Description
This peptide is an analog of a sequence of HIV-1 for which cytotoxic T lymphocytes may bind.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This peptide is an analog of a sequence of HIV-1 for which cytotoxic T lymphocytes may bind.
| Purity | ≥98% |
|---|---|
| Formula | C108H167N27O29 |
| Formula Wt. | 2307.67 |
| Synonym | HIV Endonuclease Antigenic Site; HIV Endonuclease. |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Rahman MA, Kuse N, Murakoshi H, et al. Raltegravir and elvitegravir-resistance mutation E92Q affects HLA-B*40:02-restricted HIV-1-specific CTL recognition. Microbes Infect. 2014 May;16(5):434-8. PMID: 24657622.
Endogenous catecholamine precursor, also found ...
CHK1 inhibitor.
EZH2 HMT inhibitor.
Selective estrogen receptor modulator.
GHB/GABA analog found in Valeriana officinalis;...
ITC, erucin analog.
Galactose analog, allolactose mimic, induces ac...
Bumetanide impurity
Polyether Ca2+ ionophore.
Peptide hormone, neurotensin analog found in am...
Cembranoid diterpene found in Sarcophyton glauc...
KRAS inhibitor
Quinazoline; α1-adrenergic antagonist.
Protein synthesis inhibitor, DPP2 and metallope...
Resveratrol prodrug; potential SIRT1 activator....
CDK4/6 inhibitor.
Endogenous neuropeptide hormone; somatostatin a...
Peptide used to measure in vitro calcineurin ac...
Fluoroquinolone; topoisomerase IV and bacterial...